期刊
BRITISH JOURNAL OF SURGERY
卷 103, 期 13, 页码 1887-1894出版社
WILEY-BLACKWELL
DOI: 10.1002/bjs.10296
关键词
-
类别
BackgroundThe impact of morbidity on long-term outcomes following liver resection for intrahepatic cholangiocarcinoma is currently unclear. MethodsThis was a retrospective analysis of all consecutive patients who underwent liver resection for intrahepatic cholangiocarcinoma with curative intent in 24 university hospitals between 1989 and 2009. Severe morbidity was defined as any complication of Dindo-Clavien grade III or IV. Patients with severe morbidity were compared with those without in terms of demographics, pathology, management, morbidity, overall survival, disease-free survival and time to recurrence. Independent predictors of severe morbidity were identified by multivariable analysis. ResultsA total of 522 patients were enrolled. Severe morbidity occurred in 113 patients (216 per cent) and was an independent predictor of overall survival (hazard ratio 164, 95 per cent c.i. 121 to 223), as were age at resection, multifocal disease, positive lymph node status and R0 resection margin. Severe morbidity did not emerge as an independent predictor of disease-free survival. Independent predictors of time to recurrence included severe morbidity, tumour size, multifocal disease, vascular invasion and R0 resection margin. Major hepatectomy and intraoperative transfusion were independent predictors of severe morbidity. ConclusionSevere morbidity adversely affects overall survival following liver resection for intrahepatic cholangiocarcinoma.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据